chemotherapy-naïve metastatic castration-resistant prostate cancer
Interviews and expert commentary tagged “chemotherapy-naïve metastatic castration-resistant prostate cancer” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Audio Journal of Oncology
Enzalutamide improves overall and progression-free survival in men with chemotherapy-naïve metastatic castration-resistant prostate cancer
SAN FRANCISCO— The orally administered androgen receptor blocker enzalutamide significantly extended both overall survival and radiographically determined progression-free survival in men whose metast
6 March 2014
0:00